RNA‐Seq and Human Complex Disease

Abstract

The Human Genome Project and next‐generation sequencing technologies contributed to identify disease‐causing mutations in Mendelian disorders and susceptibility loci in complex disease. Despite the progresses, studying multifactorial diseases still remains a challenge. Most of the genome‐wide association studies have not explained the causative role of nucleotide variations in complex diseases, and several polymorphisms so far identified have been shown to affect gene expression and alternative splicing. It has highlighted the importance of studying the transcriptome in the context of these diseases.

Ribonucleic acid (RNA)‐sequencing is providing an unprecedented opportunity to quantify in a single experiment – other than gene expression levels – the extent of alternative splicing and allele‐specific expression, as well as to identify novel genes, splice isoforms, chimaeric transcripts, and to investigate noncoding RNAs.

Here, the authors describe the advantages of using RNA‐Seq to study human complex diseases, paying attention to metabolic–cardiovascular disorders, neurodegenerative and neuropsychiatric diseases, and cancer.

Key Concepts:

  • Complex diseases are caused by intricate molecular interactions, involving both genetic and environmental factors. Their aetiology remains mostly unknown.

  • The causative role of single‐nucleotide polymorphisms and of other DNA variations to complex disease susceptibility has not yet been provided.

  • Most of GWAS‐associated SNPs fall in regulatory regions and directly affect gene expression levels and alternative splicing.

  • Transcriptome analysis is emerging as a promising approach to understand the impact of nucleotide variations on gene expression levels and splicing in the diseases' aetiology.

  • RNA‐Seq allows the precise quantification of expression levels of known genes, the identification of novel coding and noncoding transcripts as well as alternative splice isoforms and chimeric transcripts.

  • RNA‐Seq – based on high‐throughput sequencing – overcomes many microarray's drawbacks and represents a promising tool for transcriptomic studies.

  • Whole‐transcriptome analysis by RNA‐Seq is revealing a powerful approach to study complex diseases.

Keywords: RNA‐sequencing; complex diseases; transcriptome; gene expression; next‐generation sequencing

Figure 1.

A schematic representation of a typical RNA‐Seq experiment.

Figure 2.

Examples of RNA‐Seq data from Costa et al. shown in UCSC Genome Browser. (a), (b), and (c) show three different examples of de‐novo identified transcripts. Blue boxes indicate the exons, black blocks and arrowed lines indicate the splice junctions and red peaks represent data ‘coverage’. (a) Shows a new splicing isoform resulting from the skipping of one exon, whose presence is indicated by a novel splice junction (highlighted in red); (b) shows an example of a newly identified exon (green box), whose presence is also supported by two novel splice junctions (in red); a completely unannotated transcribed region is finally indicated in (c). Green arrows show the lack of any gene annotation in RefSeq and Ensembl databases. It is also evident that this newly identified transcript does not overlap any repeated region of the human genome.

close

References

Bahn JH, Lee JH, Li G et al. (2012) Accurate identification of A to‐I RNA editing in human by transcriptome sequencing. Genome Research 22: 142–150.

Beck D, Ayers S, Wen J et al. (2011) Integrative analysis of next generation sequencing for small non‐coding RNAs and transcriptional regulation in myelodysplastic syndromes. BMC Medical Genomics 4: 19.

Berger MF, Levin JZ, Vijayendran K et al. (2010) Integrative analysis of the melanoma transcriptome. Genome Research 20: 413–427.

Brennan EP, Morine MJ, Walsh DW et al. (2012) Next‐generation sequencing identifies TGF‐β1‐associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy. Biochimica et Biophysica Acta 1822: 589–599.

Carraro DM, Ferreira EN, Molina GdC et al. (2011) Poly (A)+ transcriptome assessment of ERBB2‐induced alterations in breast cell lines. PLoS One 6(6): e21022.

Cooper‐Knock J, Kirby J, Ferraiuolo L et al. (2012) Gene expression profiling in human neurodegenerative disease. Nature Reviews Neurology 8(9): 518–530.

Costa V, Angelini C, D'Apice L et al. (2011) Massive‐scale RNA‐Seq analysis of non ribosomal transcriptome in human trisomy 21. PLoS One 6: e18493.

Costa V, Angelini C, De Feis I et al. (2010) Uncovering the complexity of transcriptomes with RNA‐Seq. Journal of Biomedicine and Biotechnology 2010: 853916.

Costa V, Aprile M, Esposito R et al. (2013) RNA‐Seq and human complex diseases: recent accomplishments and future perspectives. European Journal of Human Genetics 21(2): 134–142.

Edgren H, Murumagi A, Kangaspeska S et al. (2011) Identification of fusion genes in breast cancer by paired‐end RNA‐sequencing. Genome Biology 12: R6.

Eizirik DL, Sammeth M, Bouckenooghe T et al. (2012) The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of proinflammatory cytokines. PLoS Genetics 8(3): e1002552.

Flockhart RJ, Webster DE, Qu K et al. (2012) BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Research 22: 1006–1014.

Freedman ML, Monteiro AN, Gayther SA et al. (2011) Principles for the post‐GWAS functional characterization of cancer risk loci. Nature Genetics 43: 513–521.

Griffith M, Griffith OL, Mwenifumbo J et al. (2010) Alternative expression analysis by RNA sequencing. Nature Methods 7(10): 843–847.

Ha KC, Lalonde E, Li L et al. (2011) Identification of gene fusion transcripts by transcriptome sequencing in BRCA1‐mutated breast cancers and cell lines. BMC Medical Genomics 4: 75.

Hsieh AC, Liu Y, Edlind MP et al. (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485: 55–61.

Huang Q, Lin B, Liu H et al. (2011) RNA‐Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS One 6(10): e26168.

Huber‐Keener KJ, Liu X, Wang Z et al. (2012) Differential gene expression in tamoxifen‐resistant breast cancer cells revealed by a new analytical model of RNA‐Seq data. PLoS One 7(7): e41333.

Jakhesara SJ, Koringa PG, Bhatt VD et al. (2013) RNA‐Seq reveals differentially expressed isoforms and novel splice variants in buccal mucosal cancer. Gene 516(1): 24–32.

Kalari KR, Rossell D, Necela BM et al. (2012) Deep sequence analysis of non‐small cell lung cancer: integrated analysis of gene expression, alternative splicing, and single nucleotide variations in lung adenocarcinomas with and without oncogenic KRAS mutations. Frontiers in Oncology 2: 12.

Kalyana‐Sundaram S, Kumar‐Sinha C, Shankar S et al. (2012) Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 149(7): 1622–1634.

Kandpal RP, Rajasimha HK, Brooks MJ et al. (2012) Transcriptome analysis using next generation sequencing reveals molecular signatures of diabetic retinopathy and efficacy of candidate drugs. Molecular Vision 18: 1123–1146.

Kannan K, Wang L, Wang J et al. (2011) Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proceedings of the National Academy of Sciences of the USA 108: 9172–9177.

Kim SC, Jung Y, Park J et al. (2013) A high‐dimensional, deep‐sequencing study of lung adenocarcinoma in female never‐smokers. PLoS One 8(2): e55596.

Kim YH, Liang H, Liu X et al. (2012) AMPKa modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. Cancer Research 72: 2512–2521.

Klevebring D, Fagerberg L, Lundberg E et al. (2010) Analysis of transcript and protein overlap in a human osteosarcoma cell line. BMC Genomics 11: 684.

Lander ES (2011) Initial impact of the sequencing of the human genome. Nature 470: 187–197.

Levin JZ, Berger MF, Adiconis X et al. (2009) Targeted next‐generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biology 10(10): R115.

Li H, Zhou H, Wang D et al. (2012) Versatile pathway‐centric approach based on highthroughput sequencing to anticancer drug discovery. Proceedings of National Academy of Sciences USA 109(12): 4609–4614.

Lin M, Pedrosa E, Shah A et al. (2011) RNA‐Seq of human neurons derived from iPS cells reveals candidate long non‐coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One 6: e23356.

Maruyama R, Shipitsin M, Choudhury S et al. (2012) Altered antisense‐to‐sense transcript ratios in breast cancer. Proceedings of the National Academy of Sciences of the USA 109(8): 2820–2824.

McElwee JL, Mohanan S, Griffith OL et al. (2012) Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer 12: 500.

Meyer JA, Wang J, Hogan LE et al. (2013) Relapse‐specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nature Genetics 45(3): 290–294.

Mills JD, Nalpathamkalam T, Jacobs HI et al. (2013) RNA‐Seq analysis of the parietal cortex in Alzheimer's disease reveals alternatively spliced isoforms related to lipid metabolism. Neuroscience Letters 536: 90–95.

Mokry M, Hatzis P, Schuijers J et al. (2012) Integrated genome‐wide analysis of transcription factor occupancy, RNA polymerase II binding and steady‐state RNA levels identify differentially regulated functional gene classes. Nucleic Acids Research 40(1): 148–158.

Morin RD, Mendez‐Lago M, Mungall AJ et al. (2011) Frequent mutation of histone‐modifying genes in non‐Hodgkin lymphoma. Nature 476: 298–303.

Nacu S, Yuan W, Kan Z et al. (2011) Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples. BMC Medical Genomics 4: 11.

Ngo VN, Young RM, Schmitz R et al. (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470(7332): 115–119.

Persson H, Kvist A, Rego N et al. (2011) Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Research 71: 78–86.

Pflueger D, Terry S, Sboner A et al. (2011) Discovery of non‐ETS gene fusions in human prostate cancer using next‐generation RNA sequencing. Genome Research 21: 56–67.

Prensner JR, Iyer MK, Balbin OA et al. (2011) Transcriptome sequencing across a prostate cancer cohort identifies PCAT‐1, an unannotated lincRNA implicated in disease progression. Nature Biotechnology 29: 742–749.

Sajnani MR, Patel AK, Bhatt VD et al. (2012) Identification of novel transcripts deregulated in buccal cancer by RNA‐seq. Gene 507: 152–158.

Sayed D and Abdellatif M (2011) MicroRNAs in development and disease. Physiological Reviews 91(3): 827–887.

Shah SP, Köbel M, Senz J et al. (2009) Mutation of FOXL2 in granulosa‐cell tumors of the ovary. New England Journal of Medicine 360: 2719–2729.

Shapiro IM, Cheng AW, Flytzanis NC et al. (2011) An EMT‐driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genetics 7: e1002218.

Song HK, Hong SE, Kim T et al. (2012) Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy. PLoS One 7(4): e35552.

Steidl C, Shah SP, Woolcock BW et al. (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471: 377–383.

Sultan M, Schulz MH, Richard H et al. (2008) A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321(5891): 956–960.

Tay Y, Kats L, Salmena L et al. (2011) Coding‐independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147(2): 344–357.

Tuch BB, Laborde RR, Xu X et al. (2010) Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One 5(2): e9317.

Twine NA, Janitz K, Wilkins MR et al. (2011) Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. PLoS One 6: e16266.

Valsesia A, Rimoldi D, Martinet D et al. (2011) Network‐guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma. PLoS One 6(4): e18369.

Wu JQ, Wang X, Beveridge NJ et al. (2012) Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS One 7(4): e36351.

Xu XL, Zhu KC, Liu F et al. (2013) Identification of somatic mutations in human prostate cancer by RNA‐Seq. Gene 519(2): 343–347.

Further Reading

Cookson W, Liang L, Abecasis G et al. (2009) Mapping complex disease traits with global gene expression. Nature Reviews Genetics 10: 184–194.

Esteller M (2011) Non‐coding RNAs in human disease. Nature Reviews Genetics 12(12): 861–874.

Feng H, Qin Z and Zhang X (2012) Opportunities and methods for studying alternative splicing in cancer with RNA‐Seq. Cancer Letters. doi:10.1016/j.canlet.2012.11.010.

McGettigan PA (2013) Transcriptomics in the RNA‐seq era. Current Opinion in Chemical Biology 17(1): 4–11.

Planas R, Pujol‐Borrell R and Vives‐Pi M (2010) Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery. Immunology Letters 133(2): 55–61.

Prokunina‐Olsson L, Muchmore B, Tang W et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nature Genetics 45(2): 164–171.

Qureshi IA and Mehler MF (2012) Emerging roles of non‐coding RNAs in brain evolution, development, plasticity and disease. Nature Reviews Neuroscience 13: 528–541.

Salmena L, Poliseno L, Tay Y et al. (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146: 353–358.

Shendure J (2008) The beginning of the end for microarrays? Nature Methods 5: 585–587.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Ciccodicola, Alfredo, Aversa, Rosanna, Esposito, Roberta, and Costa, Valerio(Sep 2013) RNA‐Seq and Human Complex Disease. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0024990]